Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571233 · ClinicalTrials.gov registry record
Biomarker Study for Heart Failure in Children With Single Ventricle Physiology
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 71
- Enrollment target
NCT00571233: Completed study, sponsored by University of California, San Francisco.
NCT00571233 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00571233 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if children with heart disease where there is only one pumping chamber("ventricle") have proteins (biomarkers") in the blood that can be used to monitor the function of their heart.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2007-02 |
| Est. Completion | 2015-01 |
What the finished NCT00571233 record still lists
NCT00571233 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 71 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00571233 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00571233 about?
NCT00571233 is a clinical study titled "Biomarker Study for Heart Failure in Children With Single Ventricle Physiology". The purpose of this study is to determine if children with heart disease where there is only one pumping chamber("ventricle") have proteins (biomarkers") in the blood that can be used to monitor the function of their heart.
What is the current status of trial NCT00571233?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2007-02. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT00571233?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia